LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 50 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,131,000 | +1.1% | 1,169,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,119,000 | -1.5% | 1,169,000 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,136,000 | +70.6% | 1,169,000 | +74.7% | 0.00% | – |
| Q4 2021 | $666,000 | +311.1% | 669,000 | +307.9% | 0.00% | – |
| Q2 2021 | $162,000 | -4.7% | 164,000 | 0.0% | 0.00% | – |
| Q1 2021 | $170,000 | +38.2% | 164,000 | +25.2% | 0.00% | – |
| Q4 2020 | $123,000 | -91.6% | 131,000 | -92.1% | 0.00% | -100.0% |
| Q2 2020 | $1,457,000 | +2873.5% | 1,661,000 | +2715.3% | 0.00% | – |
| Q1 2020 | $49,000 | +444.4% | 59,000 | +490.0% | 0.00% | – |
| Q2 2019 | $9,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|